Daoming Optics&Chemical Co.,Ltd (002632.SZ)
Yongkang, SD, CN
Daoming Optics&Chemical Co.,Ltd engages in the research and development, production, and sale of various functional films and polymer synthetic materials in China and internationally. The company offers personal protection solutions, including normal reflective fabric, reflective leather and yarn, finished, reflective clothing, heat transfer film, prismatic reflective tape, flame retardant, industrial washable, elastic reflective fabric, photoluminescent, and fancy fabric products. It also provides vehicle safety solutions, such as vehicle retro-reflective markings and finished products; and road safety solutions comprising reflective films for permanent and temporary road signs, reflective films for special purposes, license plate films, and finished and accessory products, as well as advanced materials solutions consisting of laser etched films, release materials, and decorative films. The company was founded in 2002 and is headquartered in Yongkang, China.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -7.46% | -1.74% | -9.12% | -26.89% | -18.25% | -18.31% | +21.80% | +52.47% | +55.27% | -4.86% | +83.91% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
| Rating | 2024-11 | Change |
|---|---|---|
| Strong Buy | 1 | 0 |
| Buy | 2 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
-
Revenue growth Chemicals - Specialty: +4.7%+3.5% Q1'26: -12.5% (vs Q1'25)
-
EPS growth Chemicals - Specialty: +13.2%+29.6% ★ Q1'26: -20.4% (vs Q1'25)
-
FCF margin FCF growth · Chemicals - Specialty: +44.1%+25.5% ★ Q1'26: +9.6% (vs Q1'25)
-
EBIT margin Chemicals - Specialty: +8.8%+18.0% ★ Q1'26: +18.3% (vs Q1'25)
-
ROIC Chemicals - Specialty: +5.6%+14.3% ★ Q1'26: +10.0% (vs Q1'25)
-
Share dilution Chemicals - Specialty: +0.1%+0.6% Q1'26: +0.1% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Chemicals - Specialty: 0.18×0.80× ★ Q1'26: 1.95× (vs Q1'25)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Dec 2015 actual |
Dec 2016 actual |
Dec 2017 actual |
Dec 2018 actual |
Dec 2019 actual |
Dec 2020 actual |
Dec 2021 actual |
Dec 2022 actual |
Dec 2023 actual |
Dec 2023 actual |
Dec 2025 actual |
Dec 2026 1 Rev. Ana. 1 EPS Ana. |
Dec 2027 1 Rev. Ana. 1 EPS Ana. |
Dec 2028 1 Rev. Ana. 1 EPS Ana. |
Dec 2029 1 Rev. Ana. 1 EPS Ana. |
Dec 2030 1 Rev. Ana. 1 EPS Ana. |
Dec 2031 1 Rev. Ana. 1 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
429.50M
est: 442.00M (-2.8%)
|
521.79M
est: 492.00M (+6.1%)
|
806.80M
est: 492.00M (+64.0%)
|
1.20B
est: 851.00M (+40.7%)
|
1.39B
est: 1.23B (+12.7%)
|
1.27B
est: 1.36B (-6.8%)
|
1.46B
est.
|
1.28B
est: 1.71B (-25.1%)
|
1.32B
est: 1.91B (-30.6%)
|
1.29B
est: 1.91B (-32.5%)
|
1.49B
est: 851.00M (+75.3%)
|
1.23B
1.23B – 1.23B
+45.0% YoY
|
1.36B
1.36B – 1.36B
+10.1% YoY
|
1.46B
1.46B – 1.46B
+7.6% YoY
|
1.71B
1.71B – 1.71B
+17.2% YoY
|
1.91B
1.91B – 1.91B
+11.3% YoY
|
1.91B
1.91B – 1.91B
+0.0% YoY
|
| EBITDA |
105.01M
est: 113.46M (-7.4%)
|
116.41M
est: 126.29M (-7.8%)
|
216.97M
est: 126.29M (+71.8%)
|
335.45M
est: 218.44M (+53.6%)
|
332.06M
est: 316.83M (+4.8%)
|
296.18M
est: 348.71M (-15.1%)
|
375.28M
est.
|
191.85M
est: 439.69M (-56.4%)
|
325.65M
est: 489.17M (-33.4%)
|
532.18M
est: 489.17M (+8.8%)
|
385.80M
est: 220.79M (+74.7%)
|
320.23M
320.23M – 320.23M
+45.0% YoY
|
352.45M
352.45M – 352.45M
+10.1% YoY
|
379.30M
379.30M – 379.30M
+7.6% YoY
|
444.40M
444.40M – 444.40M
+17.2% YoY
|
494.42M
494.42M – 494.42M
+11.3% YoY
|
494.42M
494.42M – 494.42M
+0.0% YoY
|
| EBIT |
54.58M
est: 74.89M (-27.1%)
|
60.62M
est: 83.36M (-27.3%)
|
153.67M
est: 83.36M (+84.3%)
|
258.14M
est: 144.18M (+79.0%)
|
242.12M
est: 209.12M (+15.8%)
|
208.82M
est: 230.16M (-9.3%)
|
247.70M
est.
|
81.73M
est: 290.21M (-71.8%)
|
197.93M
est: 322.88M (-38.7%)
|
403.54M
est: 322.88M (+25.0%)
|
268.20M
est: 145.09M (+84.9%)
|
210.43M
210.43M – 210.43M
+45.0% YoY
|
231.60M
231.60M – 231.60M
+10.1% YoY
|
249.25M
249.25M – 249.25M
+7.6% YoY
|
292.03M
292.03M – 292.03M
+17.2% YoY
|
324.90M
324.90M – 324.90M
+11.3% YoY
|
324.90M
324.90M – 324.90M
+0.0% YoY
|
| Net Income |
45.00M
est: 47.20M (-4.7%)
|
48.71M
est: 50.35M (-3.3%)
|
123.75M
est: 50.35M (+145.8%)
|
205.42M
est: 125.88M (+63.2%)
|
198.24M
est: 222.38M (-10.9%)
|
169.20M
est: 258.05M (-34.4%)
|
270.64M
est.
|
54.94M
est: 402.81M (-86.4%)
|
156.71M
est: 465.75M (-66.4%)
|
313.94M
est: 465.75M (-32.6%)
|
221.64M
est: 126.65M (+75.0%)
|
223.75M
223.75M – 223.75M
+76.7% YoY
|
259.64M
259.64M – 259.64M
+16.0% YoY
|
272.31M
272.31M – 272.31M
+4.9% YoY
|
405.29M
405.29M – 405.29M
+48.8% YoY
|
468.62M
468.62M – 468.62M
+15.6% YoY
|
468.62M
468.62M – 468.62M
+0.0% YoY
|
| SGA |
83.84M
est: 29.79M (+181.4%)
|
112.45M
est: 33.16M (+239.1%)
|
105.39M
est: 33.16M (+217.8%)
|
148.33M
est: 57.36M (+158.6%)
|
177.13M
est: 83.20M (+112.9%)
|
149.95M
est: 91.57M (+63.8%)
|
98.55M
est.
|
163.66M
est: 115.46M (+41.7%)
|
170.96M
est: 128.45M (+33.1%)
|
159.52M
est: 128.45M (+24.2%)
|
48.65M
est: 88.10M (-44.8%)
|
127.78M
127.78M – 127.78M
+45.0% YoY
|
140.63M
140.63M – 140.63M
+10.1% YoY
|
151.35M
151.35M – 151.35M
+7.6% YoY
|
177.33M
177.33M – 177.33M
+17.2% YoY
|
197.29M
197.29M – 197.29M
+11.3% YoY
|
197.29M
197.29M – 197.29M
+0.0% YoY
|
| EPS |
0.08
est: 0.08 (+6.7%)
|
0.08
est: 0.08 (+0.0%)
|
0.21
est: 0.08 (+162.5%)
|
0.33
est: 0.20 (+65.0%)
|
0.32
est: 0.35 (-9.4%)
|
0.27
est: 0.41 (-34.1%)
|
0.43
est.
|
0.09
est: 0.64 (-85.9%)
|
0.25
est: 0.74 (-66.2%)
|
0.50
est: 0.74 (-32.4%)
|
0.35
est: 0.20 (+75.0%)
|
0.35
0.35 – 0.35
+76.7% YoY
|
0.41
0.41 – 0.41
+16.0% YoY
|
0.43
0.43 – 0.43
+4.9% YoY
|
0.64
0.64 – 0.64
+48.8% YoY
|
0.74
0.74 – 0.74
+15.6% YoY
|
0.74
0.74 – 0.74
+0.0% YoY
|
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-29 | B+ | 3/5 | 4/5 | 4/5 | 5/5 | 2/5 | 1/5 | 2/5 |
| 2026-05-28 | B+ | 3/5 | 4/5 | 4/5 | 5/5 | 2/5 | 1/5 | 2/5 |
| 2026-05-27 | B+ | 3/5 | 4/5 | 4/5 | 5/5 | 2/5 | 1/5 | 2/5 |
| 2026-05-26 | B+ | 3/5 | 4/5 | 4/5 | 5/5 | 2/5 | 1/5 | 2/5 |
| 2026-05-25 | B+ | 3/5 | 4/5 | 4/5 | 5/5 | 2/5 | 1/5 | 2/5 |
| 2026-05-22 | B+ | 3/5 | 4/5 | 4/5 | 5/5 | 2/5 | 1/5 | 2/5 |
| 2026-05-21 | B+ | 3/5 | 5/5 | 4/5 | 5/5 | 2/5 | 1/5 | 2/5 |
| 2026-05-20 | B+ | 3/5 | 4/5 | 4/5 | 5/5 | 2/5 | 1/5 | 2/5 |
| 2026-05-19 | B+ | 3/5 | 4/5 | 4/5 | 5/5 | 2/5 | 1/5 | 2/5 |
| 2026-05-18 | B+ | 3/5 | 4/5 | 4/5 | 5/5 | 2/5 | 1/5 | 2/5 |
| 2026-05-15 | A- | 4/5 | 5/5 | 4/5 | 5/5 | 2/5 | 2/5 | 2/5 |
| 2026-05-14 | B+ | 3/5 | 4/5 | 4/5 | 5/5 | 2/5 | 2/5 | 2/5 |
| 2026-05-13 | B+ | 3/5 | 4/5 | 4/5 | 5/5 | 2/5 | 2/5 | 2/5 |
| 2026-05-12 | B+ | 3/5 | 4/5 | 4/5 | 5/5 | 2/5 | 2/5 | 2/5 |
| 2026-05-11 | B+ | 3/5 | 4/5 | 4/5 | 5/5 | 2/5 | 2/5 | 2/5 |
| 2026-05-08 | B+ | 3/5 | 4/5 | 4/5 | 5/5 | 2/5 | 2/5 | 2/5 |
| 2026-05-07 | B+ | 3/5 | 4/5 | 4/5 | 5/5 | 2/5 | 2/5 | 2/5 |
| 2026-05-06 | B+ | 3/5 | 4/5 | 4/5 | 5/5 | 2/5 | 2/5 | 2/5 |
| 2026-04-30 | B+ | 3/5 | 4/5 | 4/5 | 5/5 | 2/5 | 2/5 | 2/5 |
| 2026-04-29 | B | 3/5 | 4/5 | 4/5 | 5/5 | 1/5 | 1/5 | 2/5 |
| 2026-04-28 | B | 3/5 | 4/5 | 4/5 | 5/5 | 1/5 | 1/5 | 2/5 |
| 2026-04-27 | B | 3/5 | 4/5 | 4/5 | 5/5 | 1/5 | 1/5 | 2/5 |
| 2026-04-24 | B | 3/5 | 4/5 | 4/5 | 5/5 | 1/5 | 1/5 | 2/5 |
| 2026-04-23 | B | 3/5 | 4/5 | 4/5 | 5/5 | 1/5 | 1/5 | 2/5 |
| 2026-04-22 | B | 3/5 | 4/5 | 4/5 | 5/5 | 1/5 | 1/5 | 2/5 |
| 2026-04-21 | B | 3/5 | 4/5 | 4/5 | 5/5 | 1/5 | 1/5 | 2/5 |
| 2026-04-20 | B | 3/5 | 4/5 | 4/5 | 5/5 | 1/5 | 1/5 | 2/5 |
| 2026-04-17 | B | 3/5 | 4/5 | 4/5 | 5/5 | 1/5 | 1/5 | 2/5 |
| 2026-04-16 | B | 3/5 | 4/5 | 4/5 | 5/5 | 1/5 | 1/5 | 2/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
This company is not held by any ETF in our universe.
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Feng Hu | Deputy GM & Director | — | male |
| Pengyi Yuan | Financial Director | — | male |
| Tingting Qian | Board Secretary | — | female |
| Yuanrui Chen | Accounting Supervisor | — | — |
| Zhi Biao Hu | Chairman & GM | — | male |
| Zhi Xiong Hu | Vice Chairman & Deputy GM | — | male |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for 002632.SZ
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.

MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
